PetVivo Holdings Inc
PETV
$1.095 -2.23%
Exchange: OTC | Sector: Healthcare | Industry: Medical Devices
Q3 2025
Published: Feb 14, 2025

Earnings Highlights

  • Revenue of $0.58M down 2.1% year-over-year
  • EPS of $-0.09 increased by 29% from previous year
  • Gross margin of 89.5%
  • Net income of -1.76M
  • "N/A" - N/A
PETV
Company PETV

Executive Summary

PetVivo Holdings reported a Q3 2025 revenue of $583,313, up to a modest extent on a QoQ basis but down 2.1% year over year (YoY). The company delivered a gross profit of $521,816 with a very high gross margin of 89.5%, illustrating favorable product economics on the revenue recognized. However, operating expenses remained outsized relative to top-line, yielding an EBITDA loss of $1.70 million and a net loss of $1.76 million for the quarter. Diluted earnings per share stood at -$0.085, reflecting aggressive investment in infrastructure and pipeline development without commensurate near-term revenue scale. Cash burn persists: net cash used in operating activities was $0.96 million, leaving cash on hand at $28,891 at quarter-end and net debt of roughly $2.34 million against total assets of $3.11 million, signaling an ongoing funding requirement. On the positive side, the gross margin strength indicates that a scalable revenue ramp or disciplined cost management could drive a clearer path to profitability if PETV can convert pipeline opportunities and licenses into meaningful revenue.

Key Performance Indicators

Revenue
Decreasing
583.31K
QoQ: 190.61% | YoY: -2.11%
Gross Profit
Increasing
521.82K
89.46% margin
QoQ: 190.61% | YoY: 26.41%
Operating Income
Increasing
-1.76M
QoQ: 19.08% | YoY: 17.59%
Net Income
Decreasing
-1.76M
QoQ: 19.23% | YoY: -0.41%
EPS
Increasing
-0.09
QoQ: 22.55% | YoY: 29.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 0.30 -0.09 +516.4% View
Q3 2025 0.58 -0.09 -2.1% View
Q2 2025 0.20 -0.11 -3.2% View
Q1 2025 0.12 -0.11 +5.6% View
Q4 2024 0.05 -0.19 -61.6% View